Teva Pharmaceutical Industries Ltd (ADR) TEVA shares are trading higher by 60 cents (5.5 percent) at $12.35 in Wednesday's session.
After Tuesday's close, Apollo Management revealed in a 13F filing that it took a new stake in the beaten-down generic drug maker.
For the fifth day in a row, Teva's stock found support in a narrow range surrounding the $11.50 area from $11.41 to $11.52. In today's session, it bottomed at $11.49 and began to move higher.
So far, the ensuing rally found resistance just ahead of its November 6 high ($12.57) as $12.54 stands at the high for the session as of 1:07 p.m. EST.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.